The sections provide an overview of TB diagnostics, vaccines and treatment.

Quantification of investments in the development of bedaquiline finds total public and philanthropic expenditures are three to five times those of Johnson & Johnson.

The high cost of GeneXpert tests for TB leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert.

A lower price for rifapentine is just a start — communities need more than discounts to access TB preventive therapy!

Newer medicines for drug-resistant TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. 

Civil society activists storm the stage at The Union Conference to demand affordability, transparency and accountability from the TB Alliance.

Pretomanid is just one part of a regimen of multiple drugs that people need. MSF has been calling for the price of a complete DR-TB treatment course to be no higher than $500 per person.

Stop TB Partnership launches online consultation on the draft Global Plan to End TB 2018-2022; Deadline for submissions: 6 November 2019

Médecins Sans Frontières releases the 6th edition of DR-TB Drugs Under the Microscope: 5 Urgent Actions to Improve DR-TB Treatment.

7 million people receive record levels of lifesaving TB treatment but 3 million still miss out. TB remains the top infectious killer in the world.